The Top European Biotech Funding Rounds in July

10/08/2021 - 5 minutes

Nordic biotechs yielded some of Europe’s biggest biotech funding rounds in July, as did developers of cultured meat and other protein alternatives.

July saw a continuing buzz of biotech fundraising activity in Europe. In the venture capital arena, the investors Sofinnova and Panakès Partners closed new funds to target life sciences companies, including those in the medtech sector. Meanwhile, the UK government laid out the red carpet for an initiative to pump over €235M (£200M) into biotech investment funds.

In the realm of public biotech companies, stock prices — as seen from the Nasdaq Biotech Index — seem to be slowly recovering from drops earlier in the year

The biggest biotech initial public offering (IPO) from a European company was the €197M ($234M) Nasdaq listing of the Swiss genomic medicine player SOPHiA Genetics. Runners up included the Belgian agricultural biotech Biotalys, which yielded €54.6M in Euronext Brussels, and the UK firm Poolbeg Pharma, which raised €29.2M (£25M) on the London-based stock market AIM.


This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
Do you want to remove this advert? Become a member!
Do you want to remove this advert? Become a member!

You might also be interested in the following:

Support Us

Become a Member